initial public offerings (IPOs) trading on American exchanges

Thursday, June 5, 2014

Vital Therapies (VTL) began trading on the NASDAQ on 17 April 2014



Vital Therapies, Inc., a biotherapeutic company, focuses on developing a cell-based therapy for the treatment of acute liver failure. Its product candidate includes ELAD system, an extracorporeal bio-artificial liver therapy that is in Phase III clinical trials to allow the patient's own liver to regenerate to a healthy state, or to stabilize the patient until transplant. The company was formerly known as Vitagen Acquisition Corp. and changed its name to Vital Therapies, Inc. in June 2003. Vital Therapies, Inc. was founded in 2003 and is headquartered in San Diego, California.

Address

SUITE B, 15222 AVENUE OF SCIENCE
SAN DIEGO, CA 92128
United States

No comments:

Post a Comment